Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
03/2008
03/12/2008EP1897869A1 Novel compound, polymer and radiation-sensitive resin composition
03/12/2008EP1896413A1 Anthracene derivative, material for light emitting element, light emitting element, light emitting device, and electronic device
03/12/2008EP1896412A2 Oxindole derivatives
03/12/2008EP1896014A2 Chemical compounds
03/12/2008EP1539693B1 Cannabinoid receptor agonists
03/12/2008EP1539480A4 Fluorinated dendrons and self-organizing ultrahigh density nanocylinder compositions
03/12/2008CN101142185A Indoles useful in the treatment of inflammation
03/12/2008CN101142184A Sulfonamide peri-substituted bicyclics for occlusive artery disease
03/12/2008CN101142183A Mitotic kinesin inhibitors
03/12/2008CN101141956A Use of CRTH2 antagonist compounds in therapy
03/12/2008CN101139317A Organic semiconductor material containing carbazole unit and synthesis
03/12/2008CN101139316A Anthraquinone imide compound and method for making same
03/12/2008CN101139315A Method for preparing di(N-methyl phthalimide) ether
03/12/2008CN101139309A Asymmetric star-radiation shaped triphenylamine compound and uses thereof
03/12/2008CN100374459C Novel method for the synthesis of perindopril and the pharmaceutically-acceptable salts thereof
03/12/2008CN100374420C Indolamid derivatives which possess glycogenphosphorylase inhibitory activity
03/12/2008CN100374419C Cis-alkoxy-substituted spirocyclic 1-h-pyrrolidine-2,4-dione derivatives serving as pesticides
03/11/2008US7342119 Process for the synthesis of a CPLA2 inhibitor
03/11/2008US7342041 viricide; synergistic mixture with antiviral agent (ribavirin) and alpha - or pegylated interferon; Human Immunogeficiency Virus, Acquired Immune Deficiency Syndrome
03/11/2008US7342040 5-fluorooxindole-3-carboxylic acid ester
03/11/2008US7342039 Substituted indole oximes
03/11/2008US7342038 Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferation
03/11/2008US7342034 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
03/11/2008US7342029 Substituted indoles
03/11/2008US7342022 Compounds in the treatment of dementia related diseases, Alzheimer's Disease and conditions associated with glycogen synthase kinase-3
03/11/2008US7342014 Diamine derivatives
03/11/2008CA2404464C Pyrrolidine and piperidine derivatives and their use for the treatment of neurodegenerative disorders
03/11/2008CA2237297C Process for the preparation of (1s,4r)-or(1r,4s)-4-(2-amino-6-chloro-9h-purin-9-yl)-2-cyclopentene-1-methanol
03/06/2008WO2008028118A1 1h-indole-2-carboxylic acid derivatives useful as ppar modulators
03/06/2008WO2008026614A1 Method for synthesizing anthracene derivative and anthracene derivative, light emitting element, light emitting device, electronic device
03/06/2008WO2008026563A1 Hydrazine amide derivative
03/06/2008WO2008025361A1 3-(1h-indol-3-yl) indan-1-ylamine derivatives for the treatment of depression and anxiety
03/06/2008WO2008025240A1 Composition comprising amino heterocyclic compound for hair dyeing and dyeing method
03/06/2008WO2007141283A3 Salts and crystalline salt forms of an 2-indolinone derivative
03/06/2008WO2007010356A8 Process for the preparation of sulfonamide derivatives
03/06/2008US20080058535 Methods and compositions for production, formulation and use of 1 aryl-3-azabicyclo[3.1.0]hexanes
03/06/2008US20080058501 Method of Producing a Polymer Network
03/06/2008US20080058497 contacting a crude 2-aryl-3,3-bis(hydroxyaryl)phthalimidine with a purification agent, removing a 2-aryl-3-(aminoaryl)-3-(hydroxyaryl)phthalimidine compound from the crude , and producing a purified 2-aryl-3,3-bis(hydroxyaryl)phthalimidine product
03/06/2008US20080058386 1-(4-Methoxy-benzenesulfonyl)-2,3-dihydro-1H-indol-7-ylamine; inhibiting tubulin polymerization; anticarcinogenic; mitotic arrest of microtubule structure, neovascularization; angiogenesis inhibitor: atherosclerosis, rheumatoid arthritis or Crohn's disease, diabetic retinopathy, psoriasis
03/06/2008US20080058382 Polyamine compounds
03/06/2008US20080058365 Fused heterocyclic compounds
03/06/2008US20080058329 Novel indane compounds
03/06/2008US20080058320 Organic Compounds
03/06/2008US20080056989 Polyhydroxy-polysulphonyl-glucose-benz(e)indoles; absorb and fluoresce in visible region; optical diagnosis of renal and cardiac diseases and for estimation of blood volume in vivo; tomography; magnetic resonance imaging; benzoindocarbocyanines
03/06/2008CA2662274A1 Chemical compounds
03/06/2008CA2655241A1 3-(1h-indol-3-yl)indan-1-ylamine derivatives for the treatment of depression and anxiety
03/05/2008EP1893588A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
03/05/2008EP1893583A1 Substituted aryloxy-n-bicyclomethyl acetamide compounds as vr1 antagonists
03/05/2008EP1893576A1 Treatment of protein folding disorders
03/05/2008EP1893575A2 2-(1h-indolylsulfanyl)-aryl amine derivatives
03/05/2008EP1893573A1 Inhibitors of hcv replication
03/05/2008EP1893567A1 Benzanilides with insecticidal activity
03/05/2008EP1893561A1 Cinnamic, phenylpropiolic and phenylpropanoic acid derivatives useful as anti-tumour agents
03/05/2008EP1893195A2 Polymorphic forms of tegaserod maleate
03/05/2008EP1893194A1 Enhanced indolinone based protein kinase inhibitors
03/05/2008EP1368020B1 Method for identifying maxi-k channel blockers
03/05/2008CN101134757A 稠合杂环化合物 Fused heterocyclic compounds
03/05/2008CN100372855C 7-imino derivatives of camptothecin having antitumor activity
03/05/2008CN100372853C Metal porphyrin nanotube and nanoline and their preparation process
03/05/2008CN100372836C Immunotherapeutic imides/amides
03/04/2008US7339059 Benzofuran-2-yl-carbonyl- and indol-2-yl-carbonyl-trans-2,5-dimethyl-piperazine derivatives; rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, inflammatory bowel disease, asthma; inhibit the interaction between inflammatory chemokines and their receptor
03/04/2008US7338966 Substituted oxindole derivatives as tyrosine kinase inhibitors
03/04/2008US7338805 Labeling reagents, methods for synthesizing such reagents and methods for detecting biological molecules
02/2008
02/28/2008WO2008024492A2 Indolinone phenylaminopropanol derivatives and process for the preparation thereof
02/28/2008WO2008023720A1 Urea compound or salt thereof
02/28/2008WO2008023336A2 Matrix metalloproteinase inhibitors
02/28/2008WO2007138282A3 Bi-aryl or aryl-heteroaryl substituted indoles
02/28/2008WO2007022459A3 Processes and intermediates
02/28/2008WO2007016136A3 Organic nitric oxide enhancing salts of cyclooxygenase-2 selective inhibitors, compositons and methods of use
02/28/2008US20080051586 [4-Acetylamino-3-(4-chlorophenylsulfanyl)-2-methyl-1H-indol-1-yl]acetic acid; cleavage of dichloroDIPHENYL DISULFIDE to form the p-chloro thioether; reduction of nitro group; respiratory diseases
02/28/2008US20080051585 Process for the preparation of indolin-2-one derivatives useful as PR modulators
02/28/2008US20080051584 Process For The Preparation Of Perindopril And Salts Thereof
02/28/2008US20080051327 Crystals of an Aurora-A Tpx2 Complex, Tpx2 Binding Site of Aurora-A, Aurora-A Ligands and Their Use
02/28/2008US20080051321 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity
02/28/2008US20080048155 Filter and Cyanine Compound
02/28/2008CA2665804A1 Urea compound or salt thereof
02/28/2008CA2661299A1 Matrix metalloproteinase inhibitors
02/27/2008EP1892240A1 Benzoisoindole derivative, pigment composition comprising the same and colored composition
02/27/2008EP1892239A1 Inhibitors of cytosolic phospholipase A2
02/27/2008EP1891971A1 Medicinal composition for ameliorating or treating glucose intolerance, borderline diabetes, insulin resistance and hyperinsulinemia containing hypoglycemic agent
02/27/2008EP1891951A1 Viral polymerase inhibitors
02/27/2008EP1891950A1 Viral polymerase inhibitors
02/27/2008EP1891073A1 Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament
02/27/2008EP1891008A1 Oxindoles as kinase inhibitors
02/27/2008EP1891007A1 Indole derivatives having antitumor activity
02/27/2008EP1891006A2 Inhibitors of cytosolic phospholipase a2
02/27/2008EP1890703A2 Pyrimidine compounds
02/27/2008EP1615904B1 Substituted benzosulphonamides as potentiators of glutamate receptors
02/27/2008EP1248612B1 Novel compounds and compositions as protease inhibitors
02/27/2008CN101133060A Enzyme inhibitors
02/27/2008CN101133024A Amide derivatives as inhibitors of histone deacetylase
02/27/2008CN101133010A Process and intermediate compounds useful in the preparation of statins
02/27/2008CN101130517A Technique for refining carbazole
02/27/2008CN101130516A Method for purifying and enriching benzene acryloyl 5- hydroxytryptamine derivant in safflower seed
02/27/2008CN101130515A Substituted-1H- indoles compound, method for preparing the same, application and pharmaceutical composition of the same
02/27/2008CN100371325C Indenoindole ketone kind compound, its preparation method and use
02/27/2008CN100371318C Aryl sulfonamides and analogues thereof and their use in the treatment of neurodegenerative diseases
02/27/2008CN100370975C Inhibitors against the production and releaseof inflammator cytokines
02/26/2008US7335961 Magnetic random access memory array with coupled soft adjacent magnetic layer
02/26/2008US7335687 Used to treat hypercholesterolemia, hyperlipemia, arteriosclerosis, mycoses, gallstones, hyperproliferative disorders, impaired glucose tolerance, or diabetes; aminocyclohexanol derivatives; e.g. N-(4-(4-[ethyl-(2-hydroxy-ethyl)-amino]-but-1-ynyl)-cyclohexyl)-N-methyl-4-trifluoromethyl-benzenesulfonamide